近日，Richard M Bergenstal等人在杂志Lancet Diabetes Endocrinol发表了文章Continuous glucose monitoring-based metrics and the duration of ...

New insulin analogues such as the long-acting analogue insulin glargine may represent beneficial treatment options in pregnancy by ensuring that patients achieve excellent glycemic control without ...

Sanofi has followed in the footsteps of its rivals in the US insulin market with a 78% price cut for its most widely-used Lantus product starting next January. It will restrict out-of-pocket costs ...

As of 2019, 62 insulin products had been removed from the market. Luckily, there are many alternative insulins, both rapid-acting and long-acting. Zilbermint highlights Lantus (insulin glargine ...

They participated over five years during which insulin glargine, liraglutide, glimepiride and sitagliptin were compared.

GoodRx said in a statement that it is working with Sanofi to offer U.S. insulin patients a coupon for to a 30-day supply of Lantus, an insulin glargine injection and Sanofi's most widely ...

With type 2 diabetes, your body doesn't respond to insulin like usual. This condition can cause blood sugar levels to be high, leading to complications.

insulins. When entering a drug such as Lantus or Novolog, a pop-up box notes, “Your drug has a generic” that may cost less. In the case of insulin, if the generic is covered, it won’t cost ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...

“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...

A 10 ml vial of Sanofi's long-acting insulin Lantus first hit the US market at $34.81 a vial in 2001, according to data from Truven Health Analytics. Since 2014, the last time Sanofi raised the ...